https://parkinsonsnewstoday.com/news/vaccine-targeting-alpha-synuclein-moves-closer-human-trials/
0
0
12/1/22 at 1:04pm
Organization
Parkinson's News Today
An experimental vaccine that targets alpha-synuclein — whose toxic clumps drive Parkinson's — is moving into late-stage preclinical research.
Create an account
or login to join the discussion